Horrell Capital Management’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6
| Closed | -$1K | – | 217 |
|
|
2023
Q2 | $1K | Hold |
6
| – | – | ﹤0.01% | 210 |
|
|
2023
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 207 |
|
|
2022
Q4 | $2K | Hold |
6
| – | – | ﹤0.01% | 201 |
|
|
2022
Q3 | $2K | Hold |
6
| – | – | ﹤0.01% | 196 |
|
|
2022
Q2 | $2K | Hold |
6
| – | – | ﹤0.01% | 193 |
|
|
2022
Q1 | $2K | Hold |
6
| – | – | ﹤0.01% | 191 |
|
|
2021
Q4 | $2K | Hold |
6
| – | – | ﹤0.01% | 187 |
|
|
2021
Q3 | $3K | Hold |
6
| – | – | ﹤0.01% | 187 |
|
|
2021
Q2 | $3K | Hold |
6
| – | – | ﹤0.01% | 190 |
|
|
2021
Q1 | $4K | Hold |
6
| – | – | ﹤0.01% | 184 |
|
|
2020
Q4 | $3K | Hold |
6
| – | – | ﹤0.01% | 175 |
|
|
2020
Q3 | $3K | Hold |
6
| – | – | ﹤0.01% | 168 |
|
|
2020
Q2 | $3K | Hold |
6
| – | – | ﹤0.01% | 167 |
|
|
2020
Q1 | $3K | Hold |
6
| – | – | ﹤0.01% | 164 |
|
|
2019
Q4 | $3K | Hold |
6
| – | – | ﹤0.01% | 171 |
|
|
2019
Q3 | $4K | Hold |
6
| – | – | ﹤0.01% | 173 |
|
|
2019
Q2 | $4K | Hold |
6
| – | – | ﹤0.01% | 172 |
|
|
2019
Q1 | $4K | Sell |
6
-5
| -45% | -$3.33K | ﹤0.01% | 174 |
|
|
2018
Q4 | $5K | Hold |
11
| – | – | ﹤0.01% | 170 |
|
|
2018
Q3 | $10K | Hold |
11
| – | – | 0.01% | 142 |
|
|
2018
Q2 | $8K | Hold |
11
| – | – | ﹤0.01% | 151 |
|
|
2018
Q1 | $5K | Buy |
11
+5
| +83% | +$2.27K | ﹤0.01% | 159 |
|
|
2017
Q4 | $2K | Hold |
6
| – | – | ﹤0.01% | 169 |
|
|
2017
Q3 | $3K | Hold |
6
| – | – | ﹤0.01% | 167 |
|
|
2017
Q2 | $3K | Sell |
6
-8
| -57% | -$4K | ﹤0.01% | 163 |
|
|
2017
Q1 | $9K | Hold |
14
| – | – | 0.01% | 138 |
|
|
2016
Q4 | $5K | Hold |
14
| – | – | ﹤0.01% | 153 |
|
|
2016
Q3 | $4K | Hold |
14
| – | – | ﹤0.01% | 151 |
|
|
2016
Q2 | $2K | Buy |
+14
| New | +$2K | ﹤0.01% | 176 |
|